David Domzalski - Mar 31, 2025 Form 4 Insider Report for VYNE Therapeutics Inc. (VYNE)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Mutya Harsch, Attorney-in-Fact
Stock symbol
VYNE
Transactions as of
Mar 31, 2025
Transactions value $
-$48,187
Form type
4
Date filed
4/2/2025, 04:15 PM
Previous filing
Jan 23, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNE Common Stock Tax liability -$48.2K -30.5K -6.41% $1.58 446K Mar 31, 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.